Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  DHILLON PUNIT
 2. Date of Event Requiring Statement (Month/Day/Year)
01/30/2008		 3. Issuer Name and Ticker or Trading Symbol
INOVIO BIOMEDICAL CORP [INO]
(Last)
(First)
(Middle)
11494 SORRENTO VALLEY RD		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
VP, Finance & Operations
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

SAN DIEGO, CA 92121-1318		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Inovio Biomedical Corporation Common Stock 185
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Inovio Biomedical Corporation Common Stock Option 01/30/2008 07/01/2013 Inovio Biomedical Corporation Common Stock 25,000 $ 2.76 D  
Inovio Biomedical Corporation Common Stock Option 01/30/2008 08/08/2013 Inovio Biomedical Corporation Common Stock 6,250 $ 2.52 D  
Inovio Biomedical Corporation Common Stock Option 01/30/2008(1) 02/25/2015 Inovio Biomedical Corporation Common Stock 15,000 $ 4.33 D  
Inovio Biomedical Corporation Common Stock Option 01/30/2008(2) 03/23/2016 Inovio Biomedical Corporation Common Stock 35,000 $ 2.45 D  
Inovio Biomedical Corporation Common Stock Option 01/30/2008(3) 03/08/2017 Inovio Biomedical Corporation Common Stock 40,000 $ 3.16 D  
Inovio Biomedical Corporation Common Stock Option 01/30/2008(4) 05/03/2017 Inovio Biomedical Corporation Common Stcok 15,000 $ 3.75 D  
Inovio Biomedical Corporation Common Stock Warrants 01/30/2008 05/10/2009 Inovio Biomedical Corporation Common Stock 1,029 $ 8.8 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
DHILLON PUNIT
11494 SORRENTO VALLEY RD
SAN DIEGO, CA 92121-1318		       VP, Finance & Operations  

Signatures

Punit S. Dhillon 01/30/2008
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Of the 15,000 common stock options outstanding; 11,250 are exercisable on 1/30/08; and 3,750 are exercisable on 2/25/08.
(2) Of the 35,000 common stock options outstanding; 17,500 are exercisable on 1/30/08; 8,750 are exercisable on 3/23/08; and 8,750 are exercisable on 3/23/09.
(3) Of the 40,000 common stock options outstanding; 10,000 are exercisable on 1/30/08; 10,000 are exercisable on 3/8/08; 10,000 are exercisable on 3/8/09; and 10,000 are exercisable on 3/8/10.
(4) Of the 15,000 common stock options outstanding; 3,750 are exercisable on 1/30/08; 3,750 are exercisable on 5/3/08; 3,750 are exercisable on 5/3/09; and 3,750 are exercisable on 5/3/10.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.